What we do
The current neuroscience drug discovery approach has been largely unsuccessful, with few disease modifying therapies available for most brain diseases.
We are reinventing neuro drug discovery by combining human brain models, scaled biology and machine learning to decode brain disease, from genetics to neural computation. We harness the resulting deep biological insights to systematically discover and develop novel drugs with greater therapeutic potential.
Human models of brain disease
Stem cell derived organoid models of brain tissue capture disease relevant genetics, targets & cell types
Automation-enabled scaled biology
Automated culture and assay unlocks the potential of brain organoids for neuro drug discovery
Machine learning & advanced analytics
Integrated machine learning approaches refine and augment drug discovery, from target ID to IND
Neuro Drug Discovery. Reinvented.